CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
April 30th 2025
The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.
People Who Have Cancer Can Leave Behind a Couple Kinds of Legacies
October 21st 2020“The future is not yours,” says Pam Haldeman, who has metastatic breast cancer. “A way to get back a little bit of control is to be your own advocate and get aggressive in researching and going to every conference or retreat available.”
‘Don’t Sugarcoat Things’ When Someone You Know is Diagnosed with Metastatic Breast Cancer
October 21st 2020“Most kinds of breast cancer are potentially curable, but metastatic breast cancer is not,” says Kathleen Friel, lab director at the Burke Neurological Institute of Weill Cornell Medicine. “People assume, ‘Oh, you must be fine because you look fine.’ It puts a lot of expectations on us that, if somehow we’re strong enough, then we’ll beat this disease.”
Ibrance Plus Faslodex in Hormone-Driven Advanced Breast Cancer Delays Disease Progression
October 6th 2020In a clinical trial, adding the CDK4/6 inhibitor Ibrance (palbociclib) to the hormonal treatment Faslodex (fulvestrant) delayed disease progression in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.
Metastatic Breast Cancer Creates High Economic Burden Through Lost Productivity
August 19th 2020“This study has highlighted the potential benefit of supportive resources to help women with (metastatic breast cancer) guard against potentially severe cancer-related financial losses for themselves and others within their households,” the authors wrote.
Novel Combination Shows Survival Benefit in HER2-Positive Metastatic Breast Cancer
June 22nd 2020In order to combat resistance to certain treatments for patients with metastatic breast cancer, researchers look to a novel combination of pyrotinib plus Xeloda to help increase progression-free survival in patients.